demonstrated that median overall survival may be improved through a combining of gemcitabine and cisplatin although the results did not reach statistical significance [ 38 ].
← all excerpts
Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma.
1
—
—